(Q77341378)
Statements
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects (English)
Simon LS
Lanza FL
Lipsky PE
Hubbard RC
Talwalker S
Schwartz BD
Isakson PC
1 September 1998